Top Stock Research Reports For Alphabet, Roche & Amgen
Zacks Investment Research | Feb 07, 2020 12:40AM ET
Friday, February 7, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet (NASDAQ:GOOGL) (GOOGL), Roche Holding (SIX:ROG) (RHHBY) and Amgen (AMGN). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
Today's Must Read/h6
Featured Reports/h6
Per a Zacks analyst, General Electric (GE) is poised to gain from its portfolio restructuring actions, aiming expansion in Power, Aviation and Renewable Energy segments.
Per the Zacks analyst, significant rise in revenues at Sony Life, coupled with growth in Imaging & Sensing Solutions (I&SS) segment led by sales of image sensors for mobile products, is aiding Sony.
While Biogen's multiple sclerosis (MS) drug Tecfidera and spinal muscular atrophy (SMA) drug Spinraza are driving sales, competitive pressure is expected to rise in 2020 in both MS and SMA markets.
Per the Zacks analyst, Moody's is poised for growth given its diverse revenue mix and low-risk product portfolio.
Per the Zacks analyst, Schlumberger's attractive reservoir and well technologies help it to outperform its peers.
Per the Zacks analyst, the company's revenues have been increasing from sales growth, rise in premium; its strong capital position enables investment for long term growth.
Per the Zacks analyst Eaton's presence in 175 countries widens its revenue base but weakness in end market conditions is expected to have an adverse impact on the company's organic revenue growth.
Per a Zacks analyst, General Electric (GE) is poised to gain from its portfolio restructuring actions, aiming expansion in Power, Aviation and Renewable Energy segments.
Per the Zacks analyst, significant rise in revenues at Sony Life, coupled with growth in Imaging & Sensing Solutions (I&SS) segment led by sales of image sensors for mobile products, is aiding Sony.
While Biogen's multiple sclerosis (MS) drug Tecfidera and spinal muscular atrophy (SMA) drug Spinraza are driving sales, competitive pressure is expected to rise in 2020 in both MS and SMA markets.
Per the Zacks analyst, Moody's is poised for growth given its diverse revenue mix and low-risk product portfolio.
Per the Zacks analyst, Schlumberger's attractive reservoir and well technologies help it to outperform its peers.
Per the Zacks analyst, the company's revenues have been increasing from sales growth, rise in premium; its strong capital position enables investment for long term growth.
Per the Zacks analyst Eaton's presence in 175 countries widens its revenue base but weakness in end market conditions is expected to have an adverse impact on the company's organic revenue growth.
New Upgrades/h6
Per the Zacks analyst, Ralph Lauren's top line gains from consistent strength in international markets, fueled by constant-currency revenue growth of 5% and 5.4%, respectively, in Europe and Asia.
Per the Zacks analyst, Monolithic is poised to gain from robust product portfolio, high demand for smart in-car connectivity and infotainment systems. Also, design wins for high-end servers bode well.
Per the Zacks analyst Sunoco is expected to generate stable cash flows from its lucrative motor fuel distribution business in the U.S. wholesale market.
Per the Zacks analyst, Ralph Lauren's top line gains from consistent strength in international markets, fueled by constant-currency revenue growth of 5% and 5.4%, respectively, in Europe and Asia.
Per the Zacks analyst, Monolithic is poised to gain from robust product portfolio, high demand for smart in-car connectivity and infotainment systems. Also, design wins for high-end servers bode well.
Per the Zacks analyst Sunoco is expected to generate stable cash flows from its lucrative motor fuel distribution business in the U.S. wholesale market.
New Downgrades/h6
Ebbing vehicle sales in the Middle East and China amid global slowdown are likely to hurt Ford's top line growth. The Zacks analyst is also worried of high costs related to new model launches.
Per the Zacks analyst, planned maintenance activities will weigh on LyondellBasell's margins in 2020. It also faces headwind from elevated raw material and energy costs.
The Zacks Analyst is worried about the soft pricing across most transportation service lines. Deterioration in operating ratio due to tepid revenues is also concerning.
Ebbing vehicle sales in the Middle East and China amid global slowdown are likely to hurt Ford's top line growth. The Zacks analyst is also worried of high costs related to new model launches.
Per the Zacks analyst, planned maintenance activities will weigh on LyondellBasell's margins in 2020. It also faces headwind from elevated raw material and energy costs.
The Zacks Analyst is worried about the soft pricing across most transportation service lines. Deterioration in operating ratio due to tepid revenues is also concerning.
Get The News You Want
undefined Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.